Samuel Alpert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Samuel Alpert has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Han Y. Yin
SUNY Upstate Medical University, Department of Ophthalmology and Visual Sciences, Syracuse, NY, USA
2 shared publications Anny M. S. Cheng
Florida International University College of Medicine, 11200 SW, 8th St, Miami, FL, 33199, USA
1 shared publication- Anny M. S. Cheng
Department of Ophthalmology, University of Florida , 6201 W Newberry Rd, Gainesville, FL 32605
1 shared publication Jamie Nord
Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Suit L 550 Harrison St, Syracuse, NY, 13202, USA
1 shared publication- Natalie Huang
Department of Ophthalmology & Visual Sciences, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY, 13210, USA
1 shared publication Philip Kurochkin
Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Suit L 550 Harrison St, Syracuse, NY, 13202, USA
1 shared publication
Latest Publications
- Open Access
- 25 November 2021
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 24, 101237
Lichen simplex chronicus of the eyelid: A case report and literature review
- 25 November 2021
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 24, 101237
Open AccessLichen simplex chronicus of the eyelid: A case report and literature review
- Open Access
- 12 October 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-5
Self-retained cryopreserved amniotic membrane for treating severe corneal ulcers: a comparative, retrospective control study
To compare the effectiveness of self- retained cryopreserved AM as an adjuvant therapy for infectious corneal ulcers. Retrospective, case–control study of 24 eyes of 24 consecutive patients with central and paracentral corneal infectious ulcers and initial visual acuity worse than 20/200. Among them, 11 eyes of 11 patients received additional placement of self-retained cryopreserved AM. Epithelialization and Best Corrected Snellen Visual Acuity (BCSVA) were compared between the two groups. At baseline, both groups had comparable age, gender, visual acuity (VA), size and location of corneal ulcer. Patients receiving additional placement of cryopreserved AM had significantly faster epithelialization within 3.56 ± 1.78 weeks vs 5.87 ± 2.20 weeks (p = 0.01) and achieved complete epithelialization in significantly more patients (72.7% vs 23.1% p = 0.04) despite overall larger baseline defect size (32.7 ± 19.5 mm2 vs 21.5 ± 10.7 mm2, p = 0.11). Consequently, the AM group had clinically significant BCSVA (> 3 lines) (81.8% vs 38.4%, p = 0.047) and total VA improvement (log MAR 0.7 ± 0.6 vs 1.6 ± 0.9, p = 0.016) compared to the control group at the time of complete epithelialization. In-office sutureless AM may be an effective adjuvant therapy in treating sight-threatening infectious corneal ulcers by promoting faster corneal epithelialization and overall better recovery of the VA.
- 12 October 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-5
Open AccessSelf-retained cryopreserved amniotic membrane for treating severe corneal ulcers: a comparative, retrospective control study
To compare the effectiveness of self- retained cryopreserved AM as an adjuvant therapy for infectious corneal ulcers. Retrospective, case–control study of 24 eyes of 24 consecutive patients with central and paracentral corneal infectious ulcers and initial visual acuity worse than 20/200. Among them, 11 eyes of 11 patients received additional placement of self-retained cryopreserved AM. Epithelialization and Best Corrected Snellen Visual Acuity (BCSVA) were compared between the two groups. At baseline, both groups had comparable age, gender, visual acuity (VA), size and location of corneal ulcer. Patients receiving additional placement of cryopreserved AM had significantly faster epithelialization within 3.56 ± 1.78 weeks vs 5.87 ± 2.20 weeks (p = 0.01) and achieved complete epithelialization in significantly more patients (72.7% vs 23.1% p = 0.04) despite overall larger baseline defect size (32.7 ± 19.5 mm2 vs 21.5 ± 10.7 mm2, p = 0.11). Consequently, the AM group had clinically significant BCSVA (> 3 lines) (81.8% vs 38.4%, p = 0.047) and total VA improvement (log MAR 0.7 ± 0.6 vs 1.6 ± 0.9, p = 0.016) compared to the control group at the time of complete epithelialization. In-office sutureless AM may be an effective adjuvant therapy in treating sight-threatening infectious corneal ulcers by promoting faster corneal epithelialization and overall better recovery of the VA.
- Open Access
- 1 September 2020
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 19, 100761
Self-retained cryopreserved amniotic membrane in treating acute ocular graft-versus-host-disease (oGVHD)
- 1 September 2020
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 19, 100761
Open AccessSelf-retained cryopreserved amniotic membrane in treating acute ocular graft-versus-host-disease (oGVHD)